Strict monitoring and follow-up measures in place for UAE vaccine trial

@admediaoffice/ Twitter

The UAE is taking all possible measures to ensure the safety and efficacy of the COVID-19 vaccine trial which is currently underway in the country.

Volunteers signing up for the trials will be monitored for a period of at least six months with daily follow-ups as well as testing for the virus at regular intervals.

Ashish Koshy is the CEO of G42 Healthcare, which is conducting the third phase of clinical trials in cooperation with China's Sinopharm.

He told ARN's Dubai Eye on One how the entire process works.

Koshy added that if the tests are successful, the vaccine could be made available to UAE residents by early 2021.

Five thousand volunteers signed up to test the inactivated vaccine within 24 hours of authorities announcing the registration process on Thursday.

UAE nationals and residents between the ages of 18 and 60 are eligible to sign up for the study, provided they pass the medical checks.


More from Local

Coming Up on Dubai Eye

  • The Sounds of Summer with Mark Lloyd

    12:00pm - 2:00pm

    Mark Lloyd wants to help you navigate places to explore across the UAE. There will also be LIVE interviews and features, continuing the conversation on the day’s biggest news stories. Plus we’ll be playing the biggest summer tracks.

  • Afternoons with Helen Farmer

    2:00pm - 5:00pm

    Every weekday afternoon, Helen Farmer will help you to navigate the highs and lows of life in the UAE. Stay up to date with what’s happening and where to go.

On Dubai Eye

Business Breakfast